SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: The Beauty Health Company (trading as Skinhealth Systems Inc., ticker: SKIN)
Filing Date: March 12, 2026
Reporting Period: Fiscal quarter and fiscal year ended December 31, 2025
Item Reported: Item 2.02 - Results of Operations and Financial Condition
The Company issued a press release and held a conference call on March 12, 2026, to announce financial results for the period ended December 31, 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) referenced in this report.
Non-GAAP Information: The Company utilized non-GAAP financial measures in its announcement. A reconciliation of GAAP to non-GAAP results is provided in Exhibit 99.1.
Material Changes
The filing serves as a notification of the release of financial results. Specific material changes compared to prior periods are not detailed in the 8-K text itself but are disclosed in the referenced press release.
Guidance, Outlook, and Risks
Management Commentary: The Company announced results via press release and conference call. No specific guidance or outlook text is included in the 8-K body.
Disclosure Policy: The Company states it discloses material non-public information through SEC filings, press releases, conference calls, and its investor relations website (https://investors.beautyhealth.com/) to comply with Regulation FD.
Legal Disclaimer: Information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2025.
- Examine the GAAP to non-GAAP reconciliation in Exhibit 99.1 to understand adjustments made to financial metrics.
- Verify any forward-looking statements or guidance provided during the March 12, 2026, conference call.
- Confirm the Company's current liquidity position and debt obligations as detailed in the full press release.